Endothelial vasomotor function in humans: relation to the expression of endothelial nitric oxide synthase  by Behrendt, Dominik et al.
216A ABSTRACTS - Hypertension, Vascular Disease, and Prevention JACC March 6, 2002 
1034-76 SympatheUc Mechanisms In Whi te  Coat  Hypertension 
Paul A. Smith, L. N. Graham, J. B. Stoker, D. A. Mary, The Leeds Teaching Hospitals, 
Leeds, United Kingdom. 
Background: The development of target organ damage in essential hypertension (EHT) 
adversely affects prognosis, and has been partly, attdbutad to sympathetic hyperactivity. 
tt has also been reported in white coat hypertension (WHT), yet little is known about sym- 
pathetic neural discharge in this condition. We planned to establish whether sympathetic 
hyperactivity occurs in WHT patients in the clinic setting, relative to matched groups with 
EHT and normotension (NT). 
Methods: WHT patients were examined and compared to EHT and NT subjects matched 
for age and body mass index (BMI). We further matched for daytime ambulatory (Arab. 
MBP), and clinic mean blood pressure (MBP), as in Table. WHT was defined as a clinic 
blood pressure of _>140/90 mmHg (a level separating EHT from NT) with a daytime 
ambulatory blood pressure of < 130/80 mmHg. Muscle sympathetic nerve activity 
(MSNA) was measured by microneurography from the peroneal nerve and its mean fre- 
quency was expressed as bursts per 100 cardiac beats (b/100b). 
Results: Data as mean ± SEM for the 3 ~lroups in Table. 
N Age BMI (Kg/ Clinic MBP Daytime Amb.MBP MSNA 
(years) m2) (mmHg) (mmHg) (b/100b) 
NT 12 46 ± 3.9 27 ± 0.8 97 ± 2.2 91 ± 1.5 34 ± 4.4 
WHT 12 46 ± 4.0 29 ± 0.9 115 ± 1.9 92 ± 0.8 47 ± 3.8 
EHT 12 47±3.2 27±0.9 113±1.3 106±1.2 58±2.6 
Using One Way Analysis of Variance, MSNA was significantly (p < 0.05) greater in WHT 
than NT, but was significantly (p < 0.05) less than in EHT. 
Conclusion: It was shown that central sympathetic output was greater in WHT than NT in 
the clinic setting, though it was not as excessive as that seen in EHT. The findings sug- 
gest that WHT is not entirely benign, and that sympathetic hyperactivity may be responsi- 
ble for development of target organ damage in this group of patients. 
the effects of 6 months intensified blood pressure (BP) and (where appropriate) lipid-low- 
ering treatment were investigated. 
Results: TF correlated positively with blood pressure, as well as CHD/CVA risk scores 
(all p<0.001), and negatively with FMD (p<0.001). Plasma levels of TF correlated posi- 
tively with VEGF (Spearman, r=0.640) and vWf (r=0.382), with a negative correlation 
between TF levels and FMD (r=-0.578; all p<0.001). 
Conclusion: In hypertension, the processes of thrombogenesis, endothelial function and 
angiogenesis are abnormal, and correlate with overall cardiovascular isk and with each 
other. Indices of endothelial dysfunction, thrombogenesis and angiogenesis might there- 
fore be useful tools to identity patients at risk. These indices are beneficially affected by 
intensive BP/lipid treatment. 
Controls Hypertensives Hypertensives affer p-value p-value 
[n=48] atBaseline 6monthstreatment (controls vs. (baseline 
[n=76] hypertensives) vs. after 
6 
months) 
Age [years] 62 (8) 64 (8) 0.280 
male:female 41:7 71:5 0.142 
total 5.6 (1.0) 5.8 (1.1) 5.3 (1.3) 0.156 <0.001 
cholesterol 
[mmol/I] 
SBP [mmHg] 134 (13) 167 (15) 144 (13) <0.001 <0.001 
DBP [mmHg] 80 (8) 92 (11) 83 (10) <0.001 <0.001 
FMD [%] 8.6 (2.2) 4.8 (1.3) 7.3 (1.7) <0.001 <0.001 
NID [%] 20.5 (2.3) 19.7 (5.7) 19.9 (6.2) 0.150 0.126 
vWf [IU/dl] 98 (19) 138 (28) 129 (33) <0.001 <0.001 
VEGF [pg/ml] 100(46-200) 400 (210-1450) 270 (180-1050) <0.001 <0.001 
TF [ng/ml] 10 (10-16) 83 (41-210) 65 (25-130) <0.001 <0.001 
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1056-77 Effects of Systemic Hyperinsulinemia on Flow-Mediated 
Dilation of the Brachial Artery in Normal Subjects 
Umberto Camoia. Gall Sullivan, Melissa B. Bryant, Carmine Cardillo, Julio A. Panza, 
Cardiology Branch - NHLB/ - NIH, Bethesda, Maryland. 
Background: Insulin resistance, and the concomitant hyberinsulinemia, are associated 
with premature development of atherosclerosis. However, acute hyperinsutinemia has 
been shown to increase nitric oxide release in the microcirculation, a potentially antiath- 
erosclerotic effect. The actions of insulin on conduit vessels have not been elucidated. 
Therefore, the purpose of this study was to investigate the effects of acute hypednsuline- 
mia on brachial artery endothelial function in healthy subjects. 
Methods: To this end, we studied endothelium-dependent (post-hyperemia flow-medi- 
ated dilation) and -independent (nitroglycerin) vascular responses of the brachial artery 
by high-rasolution ultrasound imaging before and during systemic hyperinsulinemia. 
Eleven healthy subjects (8 men and 3 women; age 47_+10 years) participated in this 
study. 
Results: Brachial artery diameter was similar at baseline and during hyperinsulinemia 
(4.6±0.7 mm and 4.8±0.8 ram, respectively; P=0.38). Similarly, mean reactive hyperemia 
after cuff deflation was unaffected by hyperinsulinemia (545±387% before and 
610~:J17% during insulin infusion; P=0.83). Flow-mediated dilation was significantly 
lower during hyperinsulinemia compared to baseline (3.9±1.3% vs 8±2.4%, respectively; 
P=0.0002). In contrast, the decrease in nitroglycerin-mediated dilation during hyperin- 
sulinemia did not reach statistical significance (9.7±3.4 during insulin infusion vs 
12±4.2% at baseline; P=0.17). 
Conclusions: These findings indicate that, in healthy subjects, acute systemic hyperin- 
sulinemia impairs endothelium-dependent vasodilation of conduit vessels, suggesting a 
potential link between chronic hyperinsulinemic states and the increased cardiovascular 
risk associated with these conditions. 
1056-78 Thrombogenesis, Angiogenesis, and Endothelial 
Function in Hypertension 
Dirk C. Felmeden, Charles G. Spencer, Natali A. Chung, Funmi M. Belgore, Andrew D. 
Blann, Gareth D. Beevers, Gregory Y. Lip, Haemostasis, Thrombosis, and Vascular 
Biology Unit, University Department of Medicine, City Hospital, Birmingham, United 
Kingdom. 
Background: Hypertensive patients are at risk of cardiovascular complications, related to 
endothelial dysfunction, thrombogenesis, and possibly abnormal angiogenesis. These 
processes can be assessed by flow-mediated ilatation (FMD), plasma levels of yon Will- 
ebrand Factor (vWF) [indices of endothelial dysfunction], tissue factor (TF) [index of 
thrambogenesis], and vascular endothelial growth factor (VEGF) [index of angiogenesis]. 
Methods: We studied 76 high-risk hypertensives (71 males; mean age 64) and related 
them to patient's cardiovascular (CHD) and cerabrovascular (CVA) risk, using the 
Framingham equation. These were compared with 48 healthy controls. In hypertensives, 
1056-79 Captopril Increases Endogenous Circulating Plasma 
Bradykinin Concentrations and Improves Endothelial 
Vseod i la tory  Function in the Human Forearm 
Thomas Leoo, JQrg Nussberger, Lars Lind, Bengt yon zur MQhlen, Thomas Kahan, 
Karolinska Institutet Danderyd Hospital, Stockholm, Sweden, Centre Hospitalier 
Universitaire Vaudois, Lausanne, Switzerland. 
Background: The renin-angiotensin system plays a pivotal role in peripheral vascular 
control. Furthermore, bradykinin (BK) has been proposed to be an important endogenous 
factor for nitric oxide release and endothelium dependent vasodilatation. However, 
endogenous plasma concentrations of BK have previously not been well studied. 
Methods: We studied 12 healthy non-smoking subjects (mean age 22 ys, mean blood 
pressure 110/67 mmHg). In the forearm circulation we examined endogenous plasma 
concentrations of BK and angiotensin (Ang) I and II (HPLC followed by RIA), forearm 
blood flow (venous occlusion pletysmography) and endothelium dependent and indepen- 
dent vasodilatation (i.a. metacholine and sodium nitroprusside, respectively). 
Results: In the control situation, arterial and venous BK concentrations and the veno- 
arterial concentration difference were 1.3±0.4, 2.4±0.6 and +1.1±0.5 (P<0.05) pmol/I, 
respectively. Corresponding values for Ang I were 3.7±0.7, 6.6±1.0 and +2.9±0,5 
(P<0.01) pmol/I, and for Ang II 3.8±0.5, 3.0±0.5, and -0.9±0.2 (P<0.01) pmogl, respec- 
tively. Within 60 min of a single 50 mg dose of captopril per os arterial BK increased to 
3.9±1.4 pmoUI (P<0.05), with little influence on venous BK (2.8±0.6 pmol/I). Captopril 
markedly increased arterial Ang I (to 39.9±14.9 pmol/I, P<0.01) and decreased Ang II (to 
0.2±0.1 pmol/I, P<0.01). Endothelial vasodilatory function improved by 16±5% (P<0.05) 
following captopril, with no influence on systemic blood pressure or basal blood flow. 
Conclusion: We demonstrate for the first time a net overflow of endogenous BK in the 
human forearm circulation. A single 50 mg dose of captopril markedly inhibits ACE with 
profound reductions in circulating Ang II concentrations. Captopdl increases arterial BK 
concentrations and augments endothelial vasodilatory function. Thus, improved endothe- 
lial vasodilatory function by ACE-inhibitor therapy may due to the concomitant increased 
availability of endogenous BK. 
:1056-80 Endothelial Vasomotor Function in Humans: Relation to 
the Expression of Endothelial Nitric Oxide Synthase 
Dominik Behrandt. James K. Liao, Scott Kinlay, Mark A. Craager, Andrew P. Selwyn, 
Peter Ganz, Brigham and Women's Hospital, Boston, Massachusetts. 
Background: The bioavailability of nitric oxide is reduced in coronary and peripheral 
srtaries of patients with cardiovascular isk factors and/or atherosclerosis but the molec- 
ular basis for this impairment is incompletely understood. Accordingly, in 17 patients 
undergoing cardiac catheterization for investigation of chest pain, we correlated the 
expression of m-RNA for endothelial nitric oxide synthase (e-NOS) from skin biopsies 
and platalets with coronary and brachial nitric oxide dependent vasomotor responses. 
Methods and Results: The coronary responses were assessed with acetylcholine using 
quantitative angiography end ranged from 7% dilation to -50% constriction (-18±18%, 
mean+ SD, n=10). The brachial responses were assessed by ultrasound during reactive 
hyperemia and ranged from -3% to +11% (5+4%, n=17), e-NOS was measured with 
semiquantitative RT-PCR. Values were normalized to GAPDH and ranged from 0.66 to 
2.35 in the skin and from 0.96 to 2.36 in platelets. The coronary responses to acetylcho- 
line were inversely related to the expression of e-NOB in the skin (r=-0.9, p<0.001). Bra- 
chial flow-mediated dilation revealed a similar but weaker trend of inversely correlating 
with e-NOS (r=-0.34, p=0.19). There was no correlation between platelet e-NOS expres- 
sion and coronary or brachial vasomotor responses. 
Conclusions: In humans, expression of e-NOS mRNA in tissues increases with failure of 
endothelium-dependent vasodilstion. Thus, in humans as in experimental studies, the 
JACC 
transcriptional control of e-NOS (i.e. mRNA) is not impaired and appears to be upregu- 
latod in the presence of vascular dysfunction. Measurement of tissue expression of 
mRNA for e-NOS is a novel indicator of vascular dysfunction that may be helpful in 
mechanistic studies. 
1056-81 The Combination of Renin-Angiotensin System 
Inhibitors and HMG-CoA Reductaee Inhibitore in 
Atherosclerosis: Effects on Vascular Endothelial 
Function 
Bobbv V. Khan, Wright B. Lauten, Syed T. Rahman, Qamar A. Khan, Sampath 
Parthasa~'athy, Emory University School of Medicine, Atlanta, Georgia. 
Background: Endothelial dysfunction plays a fundamental role through which cardiovas- 
cular risk factors contribute to atherosclerosis. Severat pharmacological gents, including 
HMG-CoA reductase (HMGR) inhibitors and renin-angiotensin system (RAS) inhibitors, 
appear to possess cardioprotactive effects via mechanisms that may reverse vascular 
endothelial dysfunction in atherosclerosis. 
Methods: We studied t24 normotensive and hyperlipidemic patients with stable coro- 
nary artery disease on a medical regimen including aspirin (CON). The patients were 
treated with the HMGR inhibitor atorvastatin (ATO, 10-40 rag/day) to obtain a serum LDL 
cholesterol of <100 mg/dl. The subjects were then randomized to either of two RAS inhib- 
itors: the angiotensin converting enzyme inhibitor quinapril (QUI, n=65, 20 mg/day) or the 
angiotensin II type 1 receptor inhibitor irbesartan (IRB, n=59, 150 mg,'day) for 12 weeks. 
Results: Using ELISA analysis, treatment with ATO slightly reduced serum soluble vas- 
cular cell adhesion molecule-1 (sVCAM-1) levels from CON (CON: 433±72; ATO: 382±58 
ng/ml, p<0.084). Moreover, the addition of QUI or IRB reduced sVCAM-1 further by 33% 
and 36% respectively (both p<0.01 from CON and ATO). Also, treatment with ATO 
reduced serum soluble interleukin-6 (slL-6) by 17% (CON: 25.3_+3.3; ATO: 21.5+~.3 ng] 
ml, p<0.045); additional therapy with QUI or IRB reduced slL-6 by 29% and 40%, respec- 
tively (both p<0.01 from CON and ATO). Treatment with ATO did not significantly affect 
the adhesion of monocytes to the monoclonal antibody CD11b, a protein with high bind- 
ing affinity to human monocytes (CON: 75±11; ATO: 78±14 percent binding, NS). How- 
ever, the addition of QUI or IRB to ATO therapy dramatically suppressed monocyte 
binding to CD11b (QUI: 34±8; IRB: 27_+9 percent binding, both p<0.01 from CON or 
ATO). 
Conclusions: These findings suggest that HMGR inhibitors and RAS inhibitors have 
functions in addition to reductions in serum cholesterol and blood pressure. Furthermore, 
the combination of these agents may significantly reduce the effects and expression of 
vascular inflammatory and oxidative mechanisms in the pathogenesis of atherosclerosis. 
1056-82 Prediction of Sites of Progression of Native Coronary 
Disease In-Vivo Based on Identification of Sites of Low 
Endothelial Shear Stress 
Peter H. Stone. Ahmet U. Coskun, Scott Kinlay, Maureen E. Clark, Milan Sonka, Andreas 
Wahle, Olusegun J. Ilegbusi, Jeffrey J. Popma, Richard E. Kuntz, Charles L. Feldman, 
Brigham & Women's Hospital, Boston, Massachusetts, Northeastern University, Boston, 
Massachusetts. 
Background: Endothelial shear stress (ESS) plays a critical role in atherogenesis: Low 
ESS increases production of inflammatory, growth, and adhesion molecules, and corre- 
lates with atherosclerosis. Ithas previously not been possible to predict sites of coronary 
disease (CAD) progression in vivo. The purpose of this study was to determine if CAD 
progression could be predicted in vivo based on ESS. Methods: We studied 4 patients at 
baseline and after 6 mos. The 3-D anatomy of an arterial segment with luminal obstruc- 
tion < 50% was determined using intracoronary ultrasound, biplane angiography, and 
coronary flow measurements. The lumen was reassembled in accurate 3-D space; local 
ESS was calculated using computational fluid dynamics. Outer vessel dimensions (exter- 
nal elastic lamina [EEL]) and the plaque (difference between EEL and the lumen) were 
similarly reconstructed. The techniques are highly reproducible. Changes in the artery at 
6 mos were assessed by general inear regression accounting for repeated measure- 
ments. Results: Baseline ESS ranged from 3-71 dynes/cm2. Low ESS was inversely 
associated with subsequent plaque progression (p<0.001); high ESS was associated 
with outward remodeling (p<0.01). Conclusions: These results show, for the first time in 
man, that sites of CAD progression over 6 mos can be identified in vivo. This methodol- 
ogy can detect minute changes in the coronary lumen, wall, and plaque and may be used 
to identify the natural history of CAD and the vascular esponse to therapies. 
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1056-83 Bradykinin B1 Receptor Gene Polymorphism is 
Associated With Impaired Coronary Reactivity in 
Women: A Report From the NHLBI WISE Study 
Zachary Brown, Richard A. Kerensky, Susan P. McGorray, Dennis M. McNamara, Staven 
E. Reis, C. Noel Bairey Merz, George Sopko, Cad J. Pepine, Daniel F. Pauly, University 
of Florida, Gainesville, University of Pittsburgh, Pennsylvania. 
Background: Bredykinin and related peptides (terminal kinins) promote vasoditation, 
endothelial NO production, and vascular permeability. Kinin fragments interact with 
bradykinin B1 receptors (B1R), which couple to G-proteins. We hypothesized that the 
kinin system's protective ffect on the coronary circulation may be reduced in patients 
with polymorphic (deficient) alleles of the B1 R gene. 
Methods: We studied 148 women enrolled in the NHLBI-sponsored Women's Ischemia 
Syndrome Evaluation (WISE). Women underwent quantitative coronary angiography 
(QCA) and genetic analysis for the G to C polymorphism at positior~ -699 of the gene. 
Seventy women underwent intracoronary Doppler flow studies. Volumetric flow was cal- 
culated from coronary cross sectional area (CSA) and flow velocity. Measurements were 
made at baseline and in response to adenosine, acetylcholine, and nitroglycedn. Flow 
ratios with each agent o flow at baseline were calculated. 
Results: Twenty-five women (20.3%) carried the B1 R gene polymorphism. Women car- 
rying the polymorphism (CG genotype) showed a significant decrease in response to 
adenosine. Their mean flow ratio was 2.05 ± 0.30, while "wildtype" women (GG geno- 
type) had a mean ratio of 2.78 ± 0.15 (p=0.047). This change in flow ratio was due to a 
decrease in velocity (p=0.022), rather than to a change in CSA (p=0.78). Similar results 
were obtained in response to nitroglycerin. Women with the polymorphism had flow ratio 
of 2.47 ± 0.24 versus 3.36 + 0.14 for the wildtype genotype (p=0.029). When acetylcho- 
line (an endothelial mediator) was tested, no difference was seen by genotype (p=0.55). 
No difference by genotype was seen for age, severity of angiographic oronary artery 
disease (CAD), hypertension, diabetes, dyslipidemia, or smoking, 
Conclusion: A polymorphism in the bradykinin B1R gene is associated with impaired 
coronary reactivity in women. This association occurs independently of angiographic 
CAD, coronary risk factors, and endothelial mediated response. While some have sug- 
gested that impaired coronary reactivity may be a feature of early atherosclerosis, our 
data suggest hat intrinsic genetic factors contribute to coronary smooth muscle reactiv- 
ity, as well. 
1 056-84 Determination of Shear Stress in Patients Confirms That 
Lumen Preservation in Atheroeclerosis Is Associated 
With Shear Stress Regulation 
Jolanda J. WentzeL Elbert H. Janssen, Rob Krams, Johan C. H. Schuurbiers, Wiltem J. 
van der Giessen, Patrick W. Serruys, Pim J. de Feyter, Cornelis J. Slager, Thoraxcentre, 
Erasmus Medical Centre Rotterdam, Rotterdam, The Nether/ands, Interuniversity 
Cardio/ogy Institute of the Nether/ands, Utrecht, The Nether/ands. 
BACKGROUND: Previous studies showed that atherosclerotic plaques preferentially 
develop at average low shear stress (SS) locations. SS is known to control umen dimen- 
sions under physiological variations. We hypothesized that in the development of athero- 
sclerosis outward remodeling, while preserving the lumen, is controlled by SS. 
METHODS: In 12 atherosclerotic patients, interventionally treated for coronary lumen 
narrowing, a non-treatad angiographically normal coronary artery (lumen stenosis <50%) 
was investigated with a combined ANGiegraphic and ivUS technique (ANGUS) to pro- 
vide true 3D lumen and vessel wall geometry. Segments in between side branches were 
selected, resulting in 22 segments. The 3D reconstruction served to calculate SS by 
computational fluid dynamics, inflow for the segments was selected to deliver an average 
SS of 15 dynes]cm2 in normal reference (ref) cross sections (minimal plaque area). 
Lumen area (LA) stanosis (AS) was defined as (LA -LAref) / LAref * 100%. SS and wall 
thickness (Th) data were measured at 16 different cimumferential locations. For each 
segment, data were averaged over all cross sections. Linear regression analysis was 
used to relate Th to SS (Th=a+b*SS). Two groups were compared based on AS (AS <- 
10% and AS >-10%). 
RESULTS: For preserved lumen areas (AS>-t0%, average AS = 0.01 being not different 
from 0, p=0.8) the slope (b) of the relationship between Th and SS was negative, indicat- 
ing shear stress control (N=14, b = -6.1"10-4 ±9.8"10-4 mJ/N : p=0.036). For AS<-10% 
no relationship was observed (N=8, b = 0.9"10-4± 5.2"10-4 m3/N, p=0.6). The slopes of 
both groups were also different (p=0.038). 
CONCLUSION:These data show for the first time in coronary arteries of patients that the 
lumen preservation isobtained by SS regulation. 
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